سعر هيجى تادين 0.5 مجم / مل شراب 120 مل 2024

Hygi-tadine desloratadine 0.5 mg/ml syrup, 120 ml bottle, by DBK Pharma > Hygint Pharmaceuticals (Egypt); second-generation antihistamine.

• Relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (2 years and older) and perennial allergic rhinitis (6 months and older).Population: Patients 2 years and older (seasonal AR); 6 months and older (perennial AR, chronic idiopathic urticaria)DailyMed (U.S. National Library of Medicine)
• Symptomatic relief of pruritus and reduction in number and size of hives in chronic idiopathic urticaria (6 months and older).Population: Patients 2 years and older (seasonal AR); 6 months and older (perennial AR, chronic idiopathic urticaria)DailyMed (U.S. National Library of Medicine)

• Most common in adults/adolescents with allergic rhinitis (>=2% and above placebo): pharyngitis, dry mouth, myalgia, fatigue, somnolence, dysmenorrhoea.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Post-marketing: tachycardia, palpitations, psychomotor hyperactivity, movement disorders, seizures, hypersensitivity, elevated liver enzymes, hepatitis, increased appetite.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to desloratadine, any of its ingredients, or to loratadine.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity reactions including rash, pruritus, urticaria, oedema, dyspnoea and anaphylaxis have been reported; stop treatment if they occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Ketoconazole, erythromycin, azithromycin, fluoxetine, cimetidineIncreased plasma desloratadine and 3-hydroxydesloratadine concentrations without clinically relevant change in safety profile in controlled studies.DailyMed (U.S. National Library of Medicine)

• Limited human data are insufficient to inform a drug-associated risk of major birth defects or miscarriage; no teratogenicity in rats or rabbits at high exposures.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Desloratadine passes into breast milk; weigh the benefits of breastfeeding, the mother's clinical need and potential effects on the infant.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Desloratadine: Long-acting tricyclic histamine antagonist with selective peripheral H1-receptor antagonist activity.